首页  期刊介绍 征稿简则 编委会 期刊征订 广告服务 留言板 联系我们 English

中国应用生理学杂志 ›› 2018, Vol. 34 ›› Issue (3): 201-203.doi: 10.12047/j.cjap.5622.2018.048

• 研究论文 • 上一篇    下一篇

人参皂苷Rg2对异丙肾上腺素诱导的大鼠心室重构的保护作用

吴晓凤1, 祁琳1, 陈士金2   

  1. 1. 武警后勤学院附属医院药剂科, 天津 300162;
    2. 湖北宜昌市第二人民医院心血管内科, 宜昌 443000
  • 收稿日期:2017-08-01 修回日期:2018-02-24 出版日期:2018-05-28 发布日期:2018-09-08
  • 通讯作者: 陈士金,Tel:18908601871;E-mail:253089640@qq.com E-mail:253089640@qq.com
  • 基金资助:
    国家自然科学基金项目(81771352)

Protective effects of ginsenoside-Rg2 on ventricular remodeling induced by isoproterenol in rats

WU Xiao-feng1, QI Lin1, CHEN Shi-jin2   

  1. 1. Department of Pharmacy, Affiliated Hospital of Logistics College of Chinese People's Armed Police Force, Tianjin 300162;
    2. Department of Cardiovascular Medicine, Yichang Second People's Hospital, Yichang 443000, China
  • Received:2017-08-01 Revised:2018-02-24 Online:2018-05-28 Published:2018-09-08
  • Supported by:
    国家自然科学基金项目(81771352)

摘要: 目的:探讨人参皂苷Rg2对异丙肾上腺素诱导的心室重构模型大鼠的保护作用。方法:将60只雄性Wistar大鼠随机分为对照组、心室重构模型组、人参皂苷Rg2(20、40、80 mg/kg)组和普萘洛尔(propranolol,15 mg/kg)组,n=10。采用多点皮下注射异丙肾上腺素85 mg/(kg·d),连续7 d,建立大鼠心室重构模型;对照组皮下注射等体积的生理盐水。此后按分组灌胃给药,每天1次,连续给药6 w后,使用八道生理记录仪测定血流动力学参数,并测定心脏重量和左心室重构指数。结果:与对照组相比,注射异丙肾上腺素后第7周时模型组大鼠颈动脉收缩压、舒张压、平均动脉压、心率、LVSP、+dp/dtmax、-dp/dtmax显著降低(P<0.01);而HW/BW和LVW/BW、LVDP显著升高(P<0.01)。与模型组相比,人参皂苷Rg2低、中、高剂量组和普萘洛尔组大鼠颈动脉收缩压、舒张压、平均动脉压、心率、LVSP、+dp/dtmax、-dp/dtmax显著升高(P<0.05,P<0.01);LVDP显著降低(P<0.01),而人参皂苷Rg2中、高剂量组和普萘洛尔组大鼠HW/BW和LVW/BW显著降低(P<0.01)。与普萘洛尔组相比,人参皂苷Rg2低剂量组收缩压、舒张压、平均动脉压显著降低(P<0.05,P<0.01);人参皂苷Rg2低剂量组LVDP和高剂量组LVSP和+dp/dtmax显著升高(P<0.05,P<0.01)。结论:人参皂苷Rg2对异丙肾上腺素所致的心室重构模型大鼠具有改善作用。

关键词: 人参皂苷Rg2, 异丙肾上腺素, 心室重构, 血流动力学, 大鼠

Abstract: Objective: To investigate the protective effects of ginsenoside-Rg2 on ventricular remodeling induced by isoproterenol (ISO) in rats.Methods: Sixty male Wistar rats were randomly divided into six groups, i.e. control group, ventricular remodeling model group,ginsenoside-Rg2 (20,40,80 mg/kg) groups and propranolol (15 mg/kg) group, with 10 rats in each group.The ventricular remodeling model was established in Wistar rats by subcutaneous injection with isoproterenol for seven days; the control group was given the same volume of normal saline. The rats were administrated intragastrically with ginsenoside-Rg2 or propranolol according to the group protocol above-mentioned after isoproterenol injection, once a day for 6 weeks. Then, the hemodynamic parameters were tested by an eight channel physiological recorder, and the heart weight was weighed and the left ventricular remodeling index was calculated.Results: On the 7th week after ISO injection, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood pressure (MBP), heat rate, left ventricular systolic pressure (LVSP), +dp/dtmax, -dp/dtmax in the model group were lower than those of control group (P<0.01), however, heart weight/body weight (HW/BW), left ventricular weight/body weight (LVW/BW) and left ventricular end-diastolic pressure (LVEDP) were higher significantly than those of control group (P<0.01). The levels of SBP, DBP, MBP, HR, LVSP, +dp/dtmax, -dp/dtmax in ginsenoside-Rg2 low, medium and high dose groups and propranolol group were higher than those of model group (P<0.05, P<0.01); while the levels of LVDP were lower than that of model group (P<0.05, P<0.01). The levels of HW/BW and LVW/BW in ginsenoside-Rg2 medium and high dose groups and propranolol group were lower than those of model group (P<0.01). Compared with propranolol group, the levels of SBP, DBP, MBP were significantly decreased in ginsenoside-Rg2 low dose group (P<0.05, P<0.01); the level of LVEDP in ginsenoside-Rg2 low dose group, the levels of LVSP and +dp/dtmax in ginsenoside-Rg2 high dose group were obviously increased (P<0.05, P<0.01).Conclusion: Ginsenoside-Rg2 can alleviate the ventricular remodeling induced by isoproterenol in rats.

Key words: ginsenoside-Rg2, isoproterenol, ventricular remodeling, hemodynamics, rat

版权所有 © 2015 《中国应用生理学杂志》编辑部
京ICP备16058274号-1
地址:天津市和平区大理道1号,邮编:300050  电话:022-23909086  E-mail:editor@cjap.ac.cn
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn